Pharmacovigilance analysis of polatuzumab plus bendamustine and rituximab treatment protocol: identifying comprehensive safety signals using FDA database by Fang Wu, Fang Wu, Siliang Wang, Siliang Wang, Xihui Xu, Weihui Zhang, Weihui Zhang, Jie Zhou, Jie Zhou, Runyan Niu, Runyan Niu, Wenting Cai, Wenting Cai, Yonggong Yang, Mengying Liu, Mengying Liu, Jinping Zhang, Jinping Zhang

Get full text